EPAS1 and metabolic dysfunction-associated steatohepatitis: Considering a putative role in relation to NAFLD/NASH patients, which are mostly obese individuals and/or type II diabetes patients, by inducing HIF-2α stabilization SerpinB3 may represent a factor able to deeply affect lipid metabolism.